The Human Genome Project and the rapid COVID-19 vaccine development highlight how translational approaches can lead to the development of new medications and therapies. Build the knowledge and skills to work in this exciting scientific field with our Drug Design and Discovery postgraduate degree.
Designed to nurture the next generation of bioscientists, our course enables science graduate and pharmaceutical industry professionals to build scientific methods and transferable, problem-solving skills. You can use knowledge developed on the course to pursue roles where you can improve quality of life, treat long-standing diseases and inherited disorders and apply antimicrobials against multidrug-resistant strains of bacteria.
Led by highly-experienced, research-focused academics, and delivered in our world-class laboratory setting, our course integrates classical natural products-based drug discovery methods with the exploration of molecular target-based drug discovery and molecular modelling. Collectively, this approach aims to nurture your in-depth knowledge of drug discovery and development.
Applicants should possess at least a UK lower second class honours degree (2:2) or equivalent in bioscience, biochemistry, chemistry, pharmacy medicine or related subject.
Please see our website
This programme will prepare you for career progression in the medical and pharmaceutical industries, scientific research, or teaching and academia. With growing interest in novel treatments and therapies fuelled by the COVID-19 pandemic, it is anticipated that new research and work opportunities will arise.
The broader relevance of course content can also open up career opportunities in many other professions, including cosmetic science, animal health, food science, medical laboratory research, patent law, scientific journalism and health and safety.
Trimester one
Choose one option from
Trimester two
Trimester three
Once at the heart of Britain’s Industrial Revolution, the University of Salford is now the home of 21st century creativity and learning. Its up-to-the...